Taileqi Information Technology, developer of mobile virtual diagnosis app CureFun, has completed RMB 40 mln in pre-Series A funding. The company said that it has raised a total of RMB 45 mln to date.
CureFun is a virtual diagnosis mobile app for doctors and medical students to help refine their diagnosis and treatment methods. The platform uses big data to create virtual "patients," on which users can then practice diagnosis methods such as asking about medical history, completing necessary examinations, and prescribing treatment.
Currently, CureFun has 3,000 virtual patients and more than 300 different diseases covering most common clinical diseases. Hundreds of hospitals and medical schools across 20 provinces in China use CureFun as a tool for students and doctors to teach, study, practice, test, and evaluate.
Zeng Cheng, CEO and founder of CureFun, said that the platform is currently seeking RMB 100 mln in Series A funding to further increase its R&D investment and to turn CureFun into a leading international platform for clinical medical training. In the future, the platform hopes to expand into upstream/downstream supply chains and enter the clinical diagnosis and treatment service industry.